MDSO
Medidata Solutions Inc
Medidata Solutions Inc historical holders
total: 2
Disciplined Growth Investors Medidata Solutions Inc transactions over time
- Total transactions:
- 27
- New positions:
- 1
- Sold out:
- 1
- Added:
- 9
- Reduced:
- 16
- Held since:
- 2013 Q2 or earlier
- Held for:
- 26+ quarters
- Latest activity:
- 2019 Q4
Fred Martin has been an institutional investor in Medidata Solutions Inc (MDSO) since at least 2013 Q2. According to 2026 Q1 report, Fred Martin doesn't hold any shares. In our earliest available record from 2013 Q2, Disciplined Growth Investors held 244,625 shares of MDSO. Since at least 2013 Q2, Disciplined Growth Investors has made 26 more transactions in this position.
When did Fred Martin exit their MDSO position?
Fred Martin no longer holds Medidata Solutions Inc (MDSO). They sold off their entire position in 2019 Q4, closing out an investment that began in 2013 Q2.
Estimated cost basis*
- Weighted AVG buy price:
- $56.58
- Weighted AVG sell price:
- $87.17
MDSO transactions history by Disciplined Growth Investors
27 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2019 Q4
|
0.00%
|
$91.50
|
-100% (-302,053)
|
|||
|
2019 Q3
|
0.51%
|
$91.50
|
-53.53% (-347,889)
|
|||
|
2019 Q2
|
1.09%
|
$90.51
|
-41.90% (-468,657)
|
|||
|
2019 Q1
|
1.44%
|
$73.24
|
-0.03% (-285)
|
|||
|
2018 Q4
|
1.55%
|
$67.42
|
+18.59% (+175,426)
|
|||
|
2018 Q3
|
1.16%
|
$73.31
|
+1.87% (+17,304)
|
|||
|
2018 Q2
|
1.38%
|
$80.56
|
-0.65% (-6,100)
|
|||
|
2018 Q1
|
1.15%
|
$62.81
|
+12.20% (+101,398)
|
|||
|
2017 Q4
|
1.04%
|
$63.37
|
+14.89% (+107,701)
|
|||
|
2017 Q3
|
1.18%
|
$78.06
|
-3.34% (-24,994)
|
|||
|
2017 Q2
|
1.22%
|
$78.20
|
-2.61% (-20,050)
|
|||
|
2017 Q1
|
0.99%
|
$57.69
|
-3.10% (-24,613)
|
|||
|
2016 Q4
|
0.90%
|
$49.67
|
+4.02% (+30,675)
|
|||
|
2016 Q3
|
1.01%
|
$55.76
|
-1.35% (-10,450)
|
|||
|
2016 Q2
|
0.91%
|
$46.87
|
-0.13% (-975)
|
|||
|
2016 Q1
|
0.76%
|
$38.71
|
+171.50% (+488,642)
|
|||
|
2015 Q4
|
0.35%
|
$49.29
|
-0.67% (-1,925)
|
|||
|
2015 Q3
|
0.31%
|
$42.11
|
+2.73% (+7,625)
|
|||
|
2015 Q2
|
0.37%
|
$54.32
|
-0.15% (-425)
|
|||
|
2015 Q1
|
0.32%
|
$49.04
|
+0.26% (+725)
|
|||
|
2014 Q4
|
0.32%
|
$47.75
|
-3.89% (-11,275)
|
|||
|
2014 Q3
|
0.33%
|
$44.29
|
-0.89% (-2,600)
|
|||
|
2014 Q2
|
0.33%
|
$42.81
|
-12.93% (-43,475)
|
|||
|
2014 Q1
|
0.46%
|
$54.34
|
-2.61% (-9,000)
|
|||
|
2013 Q4
|
0.54%
|
$60.50
|
+42.61% (+103,170)
|
|||
|
2013 Q3
|
0.70%
|
$98.93
|
-1.03% (-2,525)
|
|||
|
2013 Q2
|
0.61%
|
$77.45
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.